Gianna, who is also one of Melissa's godchildren, took to her TikTok account on Jan. 15, where she posted footage of Melissa's reaction to finding out the big news. Gianna had pulled Melissa into ...

James Yaro; Analyst; Goldman Sachs & Company, Inc. Brendan O’Brien; Analyst; Wolfe Research Aidan Hall; Analyst; Keefe, Bruyette & Woods, Inc. Good morning and welcome to the Evercore fourth ...

Nvidia (NASDAQ:NVDA) was added to Evercore ISI's Tactical Outperform list on Monday as analysts turned bullish ahead of the company's fiscal fourth-quarter earnings report on February 26.

Melissa Ludtke, left, and Jenny Cavnar, right, talk to an audience about Ludtke’s 2024 book “Locker Room Talk” at the Tattered Cover Book Store on Feb. 4, 2025 in Denver. This story is ...

NEW YORK--(BUSINESS WIRE)--Evercore (NYSE: EVR) announced today that David Kamo has joined the firm as a senior managing director to support its growing financial sponsor M&A advisory business ...

Little House on the Prairie star Melissa Gilbert is opening up about the real reason she left Hollywood behind. “I just didn’t feel like that was a safe place for me to age. It’s so anti ...

Evercore (NYSE: EVR) announced today that David Kamo has joined the firm as a senior managing director to support its growing financial sponsor M&A advisory business,based in New York. “We are ...

Evercore's Q4 2024 EPS of $3.41 beat the forecast of $3.04. Revenue for the quarter reached $975.33 million, surpassing expectations. Stock price increased by 1.82% in premarket trading after the ...

Rich Ross, head of technical analysis at Evercore ISI, said that a breakout to an all-time high in the S&P 500 (SP500), (SPX) and the Nasdaq 100 (QQQM), (QQQ) “is imminent.” Ross said he ...

In a report released yesterday, Amit Daryanani from Evercore ISI maintained a Buy rating on Vertiv Holdings (VRT – Research Report), with a price target of $150.00. The company’s shares closed ...

Evercore ISI upgraded CarMax (KMX) to Outperform from In Line with a price target of $110, up from $90. The firm sees the company’s improving comp and share trends persisting amid a favorable ...

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (BRSE:1CG) from In-Line to Outperform. There are 577 funds or institutions reporting ...